Literature DB >> 17155933

Identification of the sites of deoxyhaemoglobin PEGylation.

Roberto Iafelice1, Simone Cristoni, Dario Caccia, Rosaria Russo, Luigi Rossi-Bernardi, Kenneth C Lowe, Michele Perrella.   

Abstract

The 2-iminothiolane reaction with protein amino groups adds a spacer arm ending with a thiol group, which can be further treated with molecules carrying a maleimido ring. This approach is currently used for the preparation of a candidate 'blood substitute' in which human Hb (haemoglobin) is conjugated with long chains of PEG [poly(ethylene glycol)]. To identify the thiolation sites by MS, we have carried out the reaction using deoxyHb bound to inositol hexaphosphate to protect some of the residues crucial for function and NEM (N-ethylmaleimide) to block and stabilize the thiol groups prior to enzymatic digestion by trypsin and pepsin. Under the conditions for the attachment of 5-8 PEG chains per tetramer, the thiolated residues were Lys7, Lys11, Lys16, Lys56 and Lys139 and, with lower accessibility, Lys90, Lys99 and Lys60 of the a-chain and Lys8, Lys17, Lys59, Lys61 and Lys66 and, with lower accessibility, Lys65, Lys95 and Lys144 of the b-chain. The a-amino groups of a- and b-chains were not modified and the reaction of the Cysb93 residues with NEM was minor or absent. After the modification with thiolane and NEM of up to five to eight lysine residues per tetramer, the products retained a large proportion of the properties of native Hb, such as low oxygen affinity, co-operativity, effect of the modulators and stability to autoxidation. Under identical anaerobic conditions, the conjugation of the thiolated Hb tetramer with five or six chains of the maleimido derivative of 6 kDa PEG yielded products with diminished co-operativity, Hill coefficient h=1.3-1.5, still retaining a significant proportion of the effects of the modulators of oxygen affinity and stability to autoxidation. Co-operativity was apparently independent of the topological distribution of the PEGylated sites as obtained by treating partly the thiolated protein with NEM prior to PEGylation [poly(ethylene glycol)ation].

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17155933      PMCID: PMC1828880          DOI: 10.1042/BJ20061556

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

Review 1.  Peptide and protein PEGylation: a review of problems and solutions.

Authors:  F M Veronese
Journal:  Biomaterials       Date:  2001-03       Impact factor: 12.479

2.  POLYVIEW: a flexible visualization tool for structural and functional annotations of proteins.

Authors:  Aleksey A Porollo; Rafal Adamczak; Jaroslaw Meller
Journal:  Bioinformatics       Date:  2004-04-08       Impact factor: 6.937

3.  Determination of the equilibrium constants for oxygen-linked CO2 binding to human hemoglobin.

Authors:  M Perrella; G Guglielmo; A Mosca
Journal:  FEBS Lett       Date:  1977-06-15       Impact factor: 4.124

4.  Stereochemistry of cooperative effects in haemoglobin.

Authors:  M F Perutz
Journal:  Nature       Date:  1970-11-21       Impact factor: 49.962

5.  Diaspirins that cross-link beta chains of hemoglobin: bis(3,5-dibromosalicyl) succinate and bis(3,5-dibromosalicyl) fumarate.

Authors:  J A Walder; R H Zaugg; R Y Walder; J M Steele; I M Klotz
Journal:  Biochemistry       Date:  1979-10-02       Impact factor: 3.162

6.  MP4, a new nonvasoactive PEG-Hb conjugate.

Authors:  Kim D Vandegriff; Ashok Malavalli; Jerod Wooldridge; Jeff Lohman; Robert M Winslow
Journal:  Transfusion       Date:  2003-04       Impact factor: 3.157

7.  Addition of sulfhydryl groups to Escherichia coli ribosomes by protein modification with 2-iminothiolane (methyl 4-mercaptobutyrimidate).

Authors:  R Jue; J M Lambert; L R Pierce; R R Traut
Journal:  Biochemistry       Date:  1978-12-12       Impact factor: 3.162

Review 8.  The dawning era of polymer therapeutics.

Authors:  Ruth Duncan
Journal:  Nat Rev Drug Discov       Date:  2003-05       Impact factor: 84.694

Review 9.  Chemistry for peptide and protein PEGylation.

Authors:  M J Roberts; M D Bentley; J M Harris
Journal:  Adv Drug Deliv Rev       Date:  2002-06-17       Impact factor: 15.470

10.  Microvascular oxygen distribution in awake hamster window chamber model during hyperoxia.

Authors:  Amy G Tsai; Pedro Cabrales; Robert M Winslow; Marcos Intaglietta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-06-12       Impact factor: 4.733

View more
  5 in total

Review 1.  Haemoglobin-based oxygen carriers: research and reality towards an alternative to blood transfusions.

Authors:  Andrea Mozzarelli; Luca Ronda; Serena Faggiano; Stefano Bettati; Stefano Bruno
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

2.  Elucidation of PEGylation site with a combined approach of in-source fragmentation and CID MS/MS.

Authors:  Xiaojun Lu; P Clayton Gough; Michael R DeFelippis; Lihua Huang
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-25       Impact factor: 3.109

3.  Toward top-down determination of PEGylation site using MALDI in-source decay MS analysis.

Authors:  Chul Yoo; Detlev Suckau; Volker Sauerland; Michael Ronk; Minhui Ma
Journal:  J Am Soc Mass Spectrom       Date:  2008-11-01       Impact factor: 3.109

4.  Low affinity PEGylated hemoglobin from Trematomus bernacchii, a model for hemoglobin-based blood substitutes.

Authors:  Daniela Coppola; Stefano Bruno; Luca Ronda; Cristiano Viappiani; Stefania Abbruzzetti; Guido di Prisco; Cinzia Verde; Andrea Mozzarelli
Journal:  BMC Biochem       Date:  2011-12-20       Impact factor: 4.059

5.  Stability of Maleimide-PEG and Mono-Sulfone-PEG Conjugation to a Novel Engineered Cysteine in the Human Hemoglobin Alpha Subunit.

Authors:  Chris E Cooper; Matthew Bird; XiaoBo Sheng; Ji-Won Choi; Gary G A Silkstone; Michelle Simons; Natalie Syrett; Riccardo Piano; Luca Ronda; Stefano Bettati; Gianluca Paredi; Andrea Mozzarelli; Brandon J Reeder
Journal:  Front Chem       Date:  2021-07-26       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.